Structure Therapeutics Incorporation

GPCR

Equity

ISIN null / Valor 124807608

NASDAQ (2026-04-02)

USD 53.48+6.60%

Structure Therapeutics Incorporation
UMushroom community rating:

3.38 8 votes No rating yet

NegativeNeutralPositive

About company

Structure Therapeutics Incorporation leverages advanced technologies in molecular visualization, computational chemistry, and data integration to develop innovative medicines. The company focuses on creating oral small molecule drugs that aim to achieve the efficacy and specificity typically associated with biologic and peptide drugs, while addressing the limitations inherent to these traditional therapies. By integrating cutting-edge scientific techniques, Structure Therapeutics seeks to provide differentiated therapeutic solutions that enhance patient outcomes.

Summarized from source with an LLMView SourceSector: Finance

Latest Results ():

Summarized from source with an LLMView Source

Key figures

216%1Y

125%3Y

%5Y

Performance

97.0%1Y

92.5%3Y

91.8%5Y

Volatility

3789 M

Market cap (USD)

1,708,669

Daily traded volume (Shares)

28.72 / 26.04

1 day high/low (USD)

0.00 / 0.00

52 weeks high/low (USD)

01 January, 2022

Dividend ex-date

0.00

Dividend (USD)

0.00%

Dividend yield (p.a.)

0.002022

0.002023

0.002024

Est dividend (USD)

0.00%2022

0.00%2023

0.00%2024

Est dividend yield

10.00

P/E ratio

00.002022

00.002023

00.002024

Est P/E ratio

0.00

EPS (USD)

0.002022

0.002023

0.002024

Est EPS (USD)

Ratings & reviews

3.38

8 votes

Performance:

2.75

Innovation:

4.00

Society:

3.75

Nature:

3.50

Bastien Romanens

Switzerland, 02 Nov 2025

Virgil Zhu

United Kingdom, 27 Oct 2025

really depends on the news about clinical trials

****** Panggabean

United Kingdom, 26 Oct 2025

Strong innovation and a solid cash position, but the stock has been under pressure as R&D costs rise and profitability remains distant. The company’s GLP-1 pipeline offers promise, yet market sentiment reflects uncertainty about near-term returns.

EQUITIES OF THE SAME SECTOR

Man Group PLC

Man Group PLC Valor: 47498660

Annual Return

-50%0%+50%

Risk level

110

-2.06%GBP 2.56

Bankinter, SA

Bankinter, SA Valor: 3219022

Annual Return

-50%0%+50%

Risk level

110

-1.34%EUR 13.64

Kooth PLC

Kooth PLC Valor: 56824344

Annual Return

-50%0%+50%

Risk level

110

0.00%GBP 1.07

NP3 Fastigheter AB

NP3 Fastigheter AB Valor: 25668351

Annual Return

-50%0%+50%

Risk level

110

-0.60%SEK 249.50

Glarner Kantonalbank

Glarner Kantonalbank Valor: 18939665

Annual Return

-50%0%+50%

Risk level

110

-0.82%CHF 24.20

KeyCorp

KeyCorp Valor: 202895

Annual Return

-50%0%+50%

Risk level

110

0.64%USD 20.47

OneSpaWorld Holdings Limited

OneSpaWorld Holdings Limited Valor: 47011152

Annual Return

-50%0%+50%

Risk level

110

0.00%USD 23.48

First Bancorp

First Bancorp Valor: 12039337

Annual Return

-50%0%+50%

Risk level

110

0.74%USD 21.74

Private Equity Holding Ltd

Private Equity Holding Ltd Valor: 608992

Annual Return

-50%0%+50%

Risk level

110

0.00%CHF 62.00

Castle Private Equity Ltd

Castle Private Equity Ltd Valor: 4885474

Annual Return

-50%0%+50%

Risk level

110

5.03%CHF 3.34

Logos provided by Clearbit

Structure Therapeutics Incorporation

GPCR

ISIN null / Valor 124807608

Structure Therapeutics Incorporation UMushroom community rating:

Bastien Romanens

Virgil Zhu

****** Panggabean

Structure Therapeutics Incorporation
UMushroom community rating: